BeckerSmith Medical, founded with the mission to automate neuro critical care, focuses on developing, patenting, and marketing innovative medical devices for Cerebral Spinal Fluid (CSF) management. Their flagship product, FLOWSAFE, is a fully-automated, programmable drainage and monitoring system that transforms traditional CSF drains into safer, more efficient tools. The company aims to modernize and enhance the safety of CSF management, targeting healthcare providers and institutions specializing in neuro critical care.

Notable affiliated individuals include industry experts in neurology and medical device innovation, contributing to the company's robust development pipeline. BeckerSmith Medical has secured investments from leading venture capital firms in the medical technology sector. Key achievements include securing patents for their technology and successfully launching FLOWSAFE in select markets. The overall impact of BeckerSmith Medical lies in its potential to significantly improve patient outcomes and streamline neuro critical care practices.